BEYOND INC (BYON)

US6903701018 - Common Stock

10.93  -0.45 (-3.95%)

Fundamental Rating

2

Overall BYON gets a fundamental rating of 2 out of 10. We evaluated BYON against 123 industry peers in the Specialty Retail industry. BYON has a bad profitability rating. Also its financial health evaluation is rather negative. BYON is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

BYON had negative earnings in the past year.
BYON had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BYON reported negative net income in multiple years.
In multiple years BYON reported negative operating cash flow during the last 5 years.

1.2 Ratios

BYON's Return On Assets of -68.55% is on the low side compared to the rest of the industry. BYON is outperformed by 95.08% of its industry peers.
Looking at the Return On Equity, with a value of -136.03%, BYON is doing worse than 78.69% of the companies in the same industry.
Industry RankSector Rank
ROA -68.55%
ROE -136.03%
ROIC N/A
ROA(3y)-6.55%
ROA(5y)-8.47%
ROE(3y)-14.74%
ROE(5y)-27.05%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BYON has a Gross Margin of 18.49%. This is amonst the worse of the industry: BYON underperforms 82.79% of its industry peers.
In the last couple of years the Gross Margin of BYON has remained more or less at the same level.
BYON does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.25%
GM growth 5Y0.7%

2

2. Health

2.1 Basic Checks

BYON does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BYON has been increased compared to 1 year ago.
The number of shares outstanding for BYON has been increased compared to 5 years ago.
Compared to 1 year ago, BYON has a worse debt to assets ratio.

2.2 Solvency

BYON has an Altman-Z score of 1.35. This is a bad value and indicates that BYON is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.35, BYON is doing worse than 72.95% of the companies in the same industry.
A Debt/Equity ratio of 0.14 indicates that BYON is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.14, BYON is doing good in the industry, outperforming 64.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 1.35
ROIC/WACCN/A
WACC8.46%

2.3 Liquidity

A Current Ratio of 1.14 indicates that BYON should not have too much problems paying its short term obligations.
The Current ratio of BYON (1.14) is worse than 67.21% of its industry peers.
A Quick Ratio of 1.08 indicates that BYON should not have too much problems paying its short term obligations.
BYON's Quick ratio of 1.08 is fine compared to the rest of the industry. BYON outperforms 77.87% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1.08

3

3. Growth

3.1 Past

BYON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14500.00%.
The Revenue has decreased by -7.81% in the past year.
The Revenue has been decreasing by -3.04% on average over the past years.
EPS 1Y (TTM)-14500%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4550%
Revenue 1Y (TTM)-7.81%
Revenue growth 3Y-14.46%
Revenue growth 5Y-3.04%
Sales Q2Q%-5.71%

3.2 Future

Based on estimates for the next years, BYON will show a very strong growth in Earnings Per Share. The EPS will grow by 20.23% on average per year.
Based on estimates for the next years, BYON will show a quite strong growth in Revenue. The Revenue will grow by 11.03% on average per year.
EPS Next Y-87.54%
EPS Next 2Y18.25%
EPS Next 3Y22.02%
EPS Next 5Y20.23%
Revenue Next Year0.64%
Revenue Next 2Y5.88%
Revenue Next 3Y8.63%
Revenue Next 5Y11.03%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

BYON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BYON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as BYON's earnings are expected to grow with 22.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.25%
EPS Next 3Y22.02%

0

5. Dividend

5.1 Amount

No dividends for BYON!.
Industry RankSector Rank
Dividend Yield N/A

BEYOND INC

NYSE:BYON (9/16/2024, 3:19:05 PM)

10.93

-0.45 (-3.95%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap500.05M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -68.55%
ROE -136.03%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 18.49%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover3.1
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.14
Quick Ratio 1.08
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-14500%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-87.54%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-7.81%
Revenue growth 3Y-14.46%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y